Alzheimer's Early Stages: First Steps In Care and Treatment,
by Daniel Kuhn and David A. Bennett. (Hunter House, 1999 (1st
edition) , 274 pp., $14.95). This guidebook focuses on the
medical aspects of the disease and includes a comparison of
the normal aging pattern of the brain and the effects of Alzheimer's.
Discusses long-term planning, relationships, communication,
and how to stay healthy while caring for someone with Alzheimer's.
Cognitive decline and literacy among ethnically diverse
elders, by Jennifer Manly and others. (Journal of
Geriatric Psychology and Neurology, 2005, Vol. 18. pp. 213-217.)
“Racial differences in the progression
of cognitive decline in Alzheimer disease,”
by Lisa L. Barnes and others. (American Journal of Geriatric
Psychology, November 2005, Vol. 13, pp. 1-9.)
“Implementing diagnostic criteria and estimating
frequency of mild cognitive impairment in an urban community,”
by Jennifer J. Manly and others. (Archives of Neurology, November
2005, Vol. 62, pp. 1739-1746.)
“Potential ethnic modifiers in the assessment
and treatment of Alzheimer’s disease: challenges for
the future,” by Warachal E. Faison and
others. (International Psychogeriatrics, 2007, Vol. 19, pp.
“Cognitive functioning among African American
older adults,” By Sheila Black. (African
American Research Perspectives, Spring/Summer 2004, Vol. 10,
Issue 1, pp. 106-118.)
"Imaging brain amyloid in Alzheimer's disease
with Pittsburgh Compound-B," by William E. Klunk
and others. (Annals of Neurology, March 2004, Volume 55, Number
3, pp. 306-319.)
"Guidance on the use of donepezil, rivastigmine,
and galantamine for the treatment of Alzheimer's disease,"
by the National Institute for Clinical Excellence (NICE).
(Technology Appraisal Guidance No. 19, January 2001. Article
available online: www.nice.org.uk
"Efficacy of galantamine in probable vascular
dementia and Alzheimer's disease combined with cerebrovascular
disease: a randomized trial," by Timo Erkinjuntti,
et al. (Lancet, April 13, 2002, Volume 359, pp. 1283-1290.
"Galantamine for Alzheimer's disease (Cochrane
Review)," by J. Olin and L. Schneider. (Cochrane
Database Systematic Review 2001; 4: CD001747.)
"Practice parameter: management of dementia (an
evidence-based review)," by the Quality Standards
Subcommittee of the American Academy of Neurology. (Neurology,
2001, Volume 56, pp. 1154-1166.)
"Use of acetylcholinesterase inhibitors in Alzheimer's
disease," by Shehram Moghul and David Wilkinson.
(Expert Reviews in Neurotherapeutics, 2001, Volume 1, Number
1, pp. 61-69.) Article available online:
Associations and Websites
Alzheimer's Disease Education and Referral center (ADEAR)
Alzheimer's Association Statement on a Study Using Positron Emission Tomography (PET) Imaging and Pittsburgh Compound-B (PIB) to View Amyloid Deposits in the Brains of Living People with Alzheimer's Disease.
P.O. Box 8250
Silver Spring, MD 20907-8250